Lymphatic Malformation: Classification, Pathogenesis, and Therapeutic Strategies
Authors:
- Chaonan ZhangCZChaonan Zhang
- Jing LiuJLJing Liu
- Yao WangYWYao Wang
- Yingying ZhengYZYingying Zheng
- Li QiLQLi Qi
- Xiaohong ShiXSXiaohong Shi
- Ju LiuJLJu Liu
Top Cited Papers
- 23 May 2025
- journal article
- review article
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 121, 35-46
Abstract
No abstract availableKeywords
Funding Information
- Shandong First Medical University
- National Natural Science Foundation of China (82241030, 82171318)
This publication has 113 references indexed in Scilit:
- PIK3R3 is upregulated in liver cancer and activates Akt signaling to control cancer growth by regulation of CDKN1C and SMC1ACancer Medicine, 2023
- Characterization of kaposiform lymphangiomatosis tissue‐derived cellsPediatric Blood & Cancer, 2021
- Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosisPediatric Blood & Cancer, 2019
- Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective studyInternational Journal of Cancer, 2017
- Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategiesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2016
- Clinical Features and Prognosis of Generalized Lymphatic Anomaly, Kaposiform Lymphangiomatosis, and Gorham-Stout DiseasePediatric Blood & Cancer, 2016
- Sildenafil for Pediatric Orbital LymphangiomaJAMA Ophthalmology, 2013
- Long-term Outcome of Radiofrequency Ablation for Intraoral Microcystic Lymphatic MalformationJAMA Otolaryngology–Head & Neck Surgery, 2011
- Sirolimus for the treatment of complicated vascular anomalies in childrenPediatric Blood & Cancer, 2011
- Sclerotherapy of lymphangiomas of the head and neckHead & Neck, 2010